drugset / Trial / NCT04178928

Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?

NCT04178928

Phase 1/2 Unknown 40 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindDiagnostic

Summary

2\. Aim/ Objectives The aim of this study is to evaluate the clinical, laboratory and echocardiographic findings in children with SCH. To investigate the effect of replacement therapy with levothyroxine on cardiovascular risk factors in children with SCH.

Timeline

Start
2020-01
Primary completion
2021-01
Completion
2021-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified 1 ug/kg

Indications